These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35778660)

  • 1. Implications of endocrine-disrupting chemicals on polycystic ovarian syndrome: A comprehensive review.
    Jala A; Varghese B; Kaur G; Rajendiran K; Dutta R; Adela R; Borkar RM
    Environ Sci Pollut Res Int; 2022 Aug; 29(39):58484-58513. PubMed ID: 35778660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion.
    Soave I; Occhiali T; Assorgi C; Marci R; Caserta D
    Curr Med Res Opin; 2020 Apr; 36(4):693-703. PubMed ID: 32046531
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.
    Jozkowiak M; Piotrowska-Kempisty H; Kobylarek D; Gorska N; Mozdziak P; Kempisty B; Rachon D; Spaczynski RZ
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and environmental toxins.
    Rutkowska AZ; Diamanti-Kandarakis E
    Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
    Palioura E; Diamanti-Kandarakis E
    Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol-A and polycystic ovary syndrome: a review of the literature.
    Kechagias KS; Semertzidou A; Athanasiou A; Paraskevaidi M; Kyrgiou M
    Rev Environ Health; 2020 Nov; 35(4):323-331. PubMed ID: 32663175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging pollutants in etiology and pathophysiology of polycystic ovary syndrome.
    Gautam R; Prambil AM; Patel AK; Arora T
    Reprod Toxicol; 2024 Jan; 123():108515. PubMed ID: 38000646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome.
    Hewlett M; Chow E; Aschengrau A; Mahalingaiah S
    Reprod Sci; 2017 Jan; 24(1):19-27. PubMed ID: 27342273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?
    Barrett ES; Sobolewski M
    Semin Reprod Med; 2014 May; 32(3):166-76. PubMed ID: 24715511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine-disrupting chemicals and hormonal profiles in PCOS women: A comparative study between urban and rural environment.
    Patel J; Chaudhary H; Panchal S; Joshi T; Joshi R
    Reprod Toxicol; 2024 Apr; 125():108562. PubMed ID: 38417580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industrial endocrine disruptors and polycystic ovary syndrome.
    Palioura E; Diamanti-Kandarakis E
    J Endocrinol Invest; 2013 Dec; 36(11):1105-11. PubMed ID: 24445124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review.
    Merlo E; Silva IV; Cardoso RC; Graceli JB
    J Toxicol Environ Health B Crit Rev; 2018; 21(3):181-206. PubMed ID: 30015594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine disrupting chemical Bisphenol A and its potential effects on female health.
    Kawa IA; Akbar Masood ; Fatima Q; Mir SA; Jeelani H; Manzoor S; Rashid F
    Diabetes Metab Syndr; 2021; 15(3):803-811. PubMed ID: 33839640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
    Wan MLY; Co VA; El-Nezami H
    Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects.
    Palioura E; Kandaraki E; Diamanti-Kandarakis E
    Horm Mol Biol Clin Investig; 2014 Mar; 17(3):137-44. PubMed ID: 25372737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats.
    Yang Z; Shi J; Guo Z; Chen M; Wang C; He C; Zuo Z
    Chemosphere; 2019 Sep; 231():151-160. PubMed ID: 31129395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental Influences and Polycystic Ovarian Syndrome.
    Dunn AJ
    Clin Obstet Gynecol; 2021 Mar; 64(1):33-38. PubMed ID: 32701518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats.
    Patisaul HB; Mabrey N; Adewale HB; Sullivan AW
    Reprod Toxicol; 2014 Nov; 49():209-18. PubMed ID: 25242113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.
    Rachoń D
    Rev Endocr Metab Disord; 2015 Dec; 16(4):359-64. PubMed ID: 26831296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.